Dr. Russell Cohen, MD

• Gastroenterology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Chicago

  Fellowship Hospital

• Beth Israel Hosp-harvard Medical School

  Residency Hospital

• Beth Israel Hosp-harvard Medical School

  Internship Hospital

• Icahn School Of Medicine At Mount Sinai

  Medical School, 1990

• English

• Arabic

• Inflammation is an Independent Risk Factor for Colonic Neoplasia in Patients with Ulcerative Colitis: a Case-Control Study, 2013-07-17

• Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease, 2020-11-21

• Complete response of metastatic melanoma in a patient with Crohn's disease simultaneously receiving anti-a4ß7 and anti-PD1 antibodies, 2019-01-06

• Surveillance of IBD Using High Definition Colonscopes Does Not Miss Adenocarcinoma in Patients with Low Grade Dysplasia, 2016-10-04

• Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis, 2012-09-24

• Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's Disease, 2020-02-26

• Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease, 2018-01-04

• Prevalence of Antibodies Against JC Virus in Serum of Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy, 2015-05-19

• Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease, 2019-02-06

• Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis, 2019-06-11

• Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis, 2022-12-06

• Effective use of Calcineurin Inhibitors with Vedolizumab in Refractory Inflammatory Bowel Disease, 2018-05-08

• Natalizumab in Crohn's Disease: Results from a US tertiary IBD center, 2013-12-16

• Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial, 2017-04-27

• Use of Biologic Therapy by Pregnant Women with Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines, 2017-09-01

• A comparison of the risk of postoperative recurrence between African-American and Caucasian Crohn's disease patients, 2018-08-20

• Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial, 2017-03-04

• Follow-Up of Ulcerative Colitis Patients Who Have Achieved Histological Normalization, 2019-06-20

• Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease, 2017-08-24

• Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis, 2023-06-15